Latest / Research To Practice | Oncology Videos
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
Featuring an interview with Dr Bijal Shah, including the following topics:
Advent and importance of blinatumomab in the therapeutic landscape of acute lymphoblastic leukemia (ALL) (0:00)
Similarities and differences between bispecific T-cell engagers (BiTEs) and bispecific antibodies (5:51)
Rationale underlying the development of surovatamig and MK-1045; benefits of blinatumomab for patients without detectable minimal residual disease (9:56)
Extramedullary ALL, including in the CNS (13:32)
Key principles in the development and use of surovatamig and MK-1045, including structural features and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.